Commission Regulation (EC) No 1490/2003 of 25 August 2003 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
Date: 2003-08-25
Institutions: European Commission
Subjects: animal product, food standard, human nutrition, veterinary drug

26.8.2003

EN

Official Journal of the European Union

L 214/3

COMMISSION REGULATION (EC) No 1490/2003

of 25 August 2003

amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure
for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of
animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European
Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), as last amended by
Commission Regulation (EC) No 1029/2003 (2), and in parti-
cular Articles 6, 7 and 8 thereof,

Whereas:

In accordance with Regulation (EEC) No 2377/90,
maximum residue limits must be established progres-
sively for all pharmacologically active substances which
are used within the Community in veterinary medicinal
products intended for administration to food-producing
animals.

Maximum residue limits should be established only after
the examination within the Committee for Veterinary
information
Medicinal Products of all
the substance
concerning the safety of
concerned for the consumer of
foodstuffs of animal
origin and the impact of residues on the industrial
processing of foodstuffs.

the relevant

residues of

(5)

(6)

(7)

(8)

For the control of residues, as provided for in appro-
priate Community legislation, maximum residue limits
should usually be established for the target tissues of
liver or kidney. However,
the liver and kidney are
frequently removed from carcases moving in interna-
tional trade, and maximum residue limits should there-
fore also always be established for muscle or fat tissues.

In the case of veterinary medicinal products intended for
use in laying birds,
lactating animals or honey bees,
maximum residue limits must also be established for
eggs, milk or honey.

Cypermethrin and Emamectin should be inserted into
Annex I to Regulation (EEC) No 2377/90.

An adequate period should be allowed before the entry
into force of this Regulation, in order to allow Member
States to make any adjustment which may be necessary
to the authorisations to place the veterinary medicinal
products concerned on the market which have been
granted in accordance with Directive 2001/82/EC of the
European Parliament and of
to take
account of the provisions of this Regulation.

the Council (4)

(9)

The measures provided for in this Regulation are in
accordance with the opinion of the Standing Committee
on Veterinary Medicinal Products,

In establishing maximum residue limits for residues of
veterinary medicinal products in foodstuffs of animal
origin,
it is necessary to specify the animal species in
which residues may be present, the levels which may be
present in each of the relevant meat tissues obtained
from the treated animal (target tissue) and the nature of
the residue which is relevant for the monitoring of resi-
dues (marker residue).

In view of the reduced availability of veterinary medic-
for certain food-producing species (3),
inal products
maximum residue limits may be established by methods
of extrapolation from maximum residue limits set for
other species on a strictly scientific basis.

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annex I to Regulation (EEC) No 2377/90 is hereby amended as
set out in the Annex hereto.

Article 2

This Regulation shall enter
into force on the third day
following its publication in the Official Journal of the European
Union.

(1) OJ L 224, 18.8.1990, p. 1.
(2) OJ L 149, 17.6.2003, p. 15.
(3) ‘Availability of veterinary medicinal products’, Communication from
the Commission to the Council and the European Parliament,
COM(2000) 806 final.

It shall apply from the 60th day following its publication.

(4) OJ L 311, 28.11.2001, p. 1.

(1)

(2)

(3)

(4)

L 214/4

EN

Official Journal of the European Union

26.8.2003

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 25 August 2003.

For the Commission

Erkki LIIKANEN

Member of the Commission

Annex I to Regulation (EEC) No 2377/90 is amended as follows:

2.

Antiparasitic agents

2.2. Agents acting against ectoparasites

2.2.3. Pyrethroids

ANNEX

Pharmacologically active substance(s)

Marker residue

Animal species

‘Cypermethrin

Cypermethrin (sum of isomers)

Bovine

Ovine (2)

(1) Further provisions in Council Directive 93/57/EC are to be observed.
(2) Not for use in animals from which milk is produced for human consumption.’

2.3. Agents acting against endo- and ectoparasites

2.3.1. Avermectins

Target tissues

MRLs

20 µg/kg
200 µg/kg
20 µg/kg
20 µg/kg
20 µg/kg
20 µg/kg
200 µg/kg
20 µg/kg
20 µg/kg

Muscle

Fat

Liver

Kidney

Milk (1)

Muscle

Fat

Liver

Kidney

Pharmacologically active substance(s)

Marker residue

Animal species

‘Emamectin

Emamectin B1a

Fin fish

MRLs

100 µg/kg

Target tissues

Muscle and skin in natural proportions’

.

.

2
6
8
2
0
0
3

E
N

O

f
f
i
c
i
a
l

J
o
u
r
n
a
l

o
f

t
h
e

E
u
r
o
p
e
a
n
U
n
o
n

i

L

2
1
4
/
5